Skip to main content

Table 3 Intra- versus intergroup comparison of 6 min walk test at the baseline versus at 3 months follow-up for the two groups

From: Effect of carvedilol versus nebivolol on insulin resistance among non-diabetic, non-ischemic cardiomyopathy with heart failure

 

G1

G2

Intergroup

Baseline

After 3 months

Baseline

After 3 months

cP

dP

A. Mean distance walked (m)

 

322 ± 104

404 ± 108

326 ± 100

407 ± 104.0

  
 

aP < 0.001*

bP < 0.001*

0.9

0.93

B. No. of patients walked < 300 m

 

9 (36%)

3 (12%)

7 (38.9%)

2 (11.1%)

  

Intragroup t test

aP = 0.031*

bP = 0.063*

0.85

0.99

  1. *P is significant
  2. aP, intragroup comparison of group 1
  3. bP, intragroup comparison of group 2
  4. cP, intragroup comparison of group 1; intergroup comparison of group 1 and group 2 at baseline
  5. dP, intergroup comparison of group 1 and group 2 after 3 months